![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Anal Cancer - 152 Studies Found
Recruiting |
: Pembrolizumab in Refractory Metastatic Anal Cancer : Anal Cancer : 2016-09-02 : Drug: Pembrolizumab Pembrolizumab 200 mg will be administered as a 30 minute IV infusion every 3 weeks. |
Recruiting |
: Shared Decision Making With Anal Cancer Patients on Radiation Dose : Anal Cancer : 2016-05-09 :
|
Completed |
: Anal Cancer Screening Study : Anal Cancer : 2009-06-04 |
Completed |
: Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer : Anal Cancer : 2009-08-07 :
|
Terminated |
: Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer : Anal Cancer : 2003-09-10 :
|
Completed |
: Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men : Anal Cancer : 2007-07-12 |
Recruiting |
: Anal Cancer Radiotherapy Study : Anal Cancer : 2013-08-28 |
Completed |
: Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer : Anal Cancer : 2001-10-11 :
|
Recruiting |
: Individual Following in Anal Cancer With PET/CT : Anal Cancer : 2016-02-22 : Other: anal cancer Anal cancer patients with TEP TDM |
Active, not recruiting |
: A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer : Anal Cancer : 2012-08-07 :
|